Clinical Trial Update: Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission [Phase 3]

View source ↗

Summary

Phase 3 trial update on extending antiretroviral post-exposure prophylaxis for infants to reduce postnatal HIV transmission; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: HIV Infections | Phase 3 | Status: COMPLETED